The study findings demonstrate diverse neurodevelopmental profiles in treated children with/at-risk of spinal muscular atrophy type 1 associated with the magnitude and duration of SMN deficiency. Here, SMN2 is linked to hyperinsulinemic hypoglycemia, familial, 4.